Sacha Inchi for Anti-Inflammatory

Research suggests that Sacha Inchi — particularly its seed oil, seed proteins, and leaf extracts — demonstrates consistent anti-inflammatory activity across a range of laboratory, animal, and computational studies, with proposed mechanisms including modulation of pro-inflammatory cytokines, inhibition of inflammatory signaling pathways such as NF-κB, and beneficial effects attributed largely to its high omega-3 fatty acid content and bioactive protein-derived peptides. Studies indicate that both the whole oil and hydrolyzed protein fractions can reduce markers of inflammation in cell-based experiments and animal models, with one mouse study finding that Sacha Inchi leaf extract performed comparably to the anti-inflammatory drug meloxicam, and another finding that Sacha Inchi oil inhibited inflammation by approximately 62% in animal testing. The current body of evidence is composed almost entirely of in vitro studies, animal experiments, and narrative reviews, with a notable absence of human randomized controlled trials, meaning it is not yet possible to draw firm conclusions about whether these effects translate to people. Reviewers across multiple papers consistently highlight this gap and call for well-designed clinical trials to establish efficacy, safe dosing thresholds, and potential interactions before broader therapeutic use can be considered, and at least one review flags that high doses of Sacha Inchi seed oil carry documented toxicity risks that warrant caution.